Blank Rome represented bioAffinity Technologies in the offering, and Sichenzia Ross Ference Carmel represented WallachBeth Capital.bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) announced it closed a securities purchase…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
